WRF Capital
North America, Washington, United States, Seattle
Description
WRF Capital supports groundbreaking research and early-stage companies that focus on life sciences and enabling technologies.
Investor Profile
WRF Capital has made 34 investments, with 3 in the past 12 months and 9% as lead.
Stage Focus
- Series A (29%)
- Seed (24%)
- Series B (18%)
- Series Unknown (12%)
- Series C (6%)
- Series D (6%)
- Series E (3%)
- Pre Seed (3%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Artificial Intelligence (Ai)
- Therapeutics
- Pharmaceutical
- Manufacturing
- Medical Device
- Life Science
- Analytics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
